Good Pharmacovigilance Practices (GVP) - Considerations II: Pregnant and Breastfeeding Women

Download the official Good Pharmacovigilance Practices (GVP) - Considerations II: Pregnant and Breastfeeding Women regulatory document.

MRG Regulatory TeamSep 2024PDF document0

下载 PDF

本文目前仅提供英文版本，完整翻译正在准备中。

PDF

可下载文档

官方法规文档：Good Pharmacovigilance Practices (GVP) - Considerations II: Pregnant and Breastfeeding Women。请在下方预览 PDF 或下载存档。

下载 PDF 在新标签页中打开

继续阅读

查看全部

药品·文章·6 min read

MAH Requirements in Saudi Arabia: Who Can Hold an SFDA Marketing Authorization?

Who the SFDA recognizes as a marketing authorization holder (MAH) — the manufacturing-site requirement, what foreign MAHs must set up locally, the difference between MAH, local agent, and scientific office, and how authorizations transfer…

Jul 2026阅读

继续阅读

药品·文章·7 min read

SFDA Regulatory Framework for Drug Approval: Pathways, Timelines & Requirements Explained

What the SFDA Regulatory Framework for Drug Approval (Version 6.4) actually covers — the four registration pathways, verification against reference authorities, published review timelines, SDR submission rules, and what applicants are responsible for at every stage…

Jul 2026阅读

继续阅读

药品·文章·6 min read

Agency Registration Certificate (MOC) for SFDA Drug Registration: What It Is and How to Get It

The Agency Registration Certificate required in SFDA drug registration is issued by the Saudi Ministry of Commerce, not the SFDA — what the certificate is, why the SDR application asks for it, who needs it, how to obtain it, and the mistakes that get files rejected…

Jul 2026阅读

继续阅读

Good Pharmacovigilance Practices (GVP) - Considerations II: Pregnant and Breastfeeding Women

相关文章

MAH Requirements in Saudi Arabia: Who Can Hold an SFDA Marketing Authorization?

SFDA Regulatory Framework for Drug Approval: Pathways, Timelines & Requirements Explained

Agency Registration Certificate (MOC) for SFDA Drug Registration: What It Is and How to Get It